提高毒素治疗宫性 dystonia 的有效性:一个范围审查
Roberto Erro1, Marina Picillo1, Maria Teresa Pellecchia1
1Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", Neuroscience Section, University of Salerno, Via Allende 43, 84081 Baronissi, SA, Italy.
Toxins
|June 27, 2023
概括
由于剂量或注射问题,用肉毒神经毒素 (BoNT) 治疗宫性 dystonia (CD) 可能会失败. 改进目标识别和患者管理可以提高CD的BoNT治疗结果.
科学领域:
- 神经学 神经学
- 运动障碍 运动障碍
- 药理学 药理学是指药理学的学科.
背景情况:
- 宫性 dystonia (CD) 是一种慢性神经疾病,严重影响患者的生活质量.
- 肌肉内注射的肉毒神经毒素 (BoNT) 是主要的治疗方法,每12-16周注射一次.
- 相当数量的患者经历了低于最佳的反应或停止了BoNT治疗.
研究的目的:
- 为了确定导致子宫 dystonia 中 BoNT 治疗结果低于最佳的因素.
- 探索潜在的解决方案,以提高BoNT治疗CD的有效性.
- 审查有关CD管理方面的挑战和进展的当前文献.
主要方法:
- 审查现有研究的BoNT治疗失败在宫 dystonia.
- 分析因素,包括肌肉标选择,剂量,注射技术和抗体形成.
- 探索诊断和指导技术,如COL-CAP,动力学/光学方法,以及EMG/超声波.
主要成果:
- 不适当的肌肉向,错误的剂量和注射不准确是治疗失败的关键原因.
- 中和对BoNT的抗体形成可以降低治疗疗效.
- 新的分类系统 (COL-CAP) 和指导技术可以提高注射精度.
结论:
- 优化肌肉目标识别和注射精度对于CD中有效的BoNT治疗至关重要.
- 需要以患者为中心的方法,对非运动症状的认识,以及专门的康复计划.
- 解决这些因素可以改善宫性 dystonia 管理的结果和患者满意度.
相关概念视频
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
711
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
711
Skeletal Muscle Relaxants: Therapeutic Uses
520
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
520
Depolarizing Blockers: Pharmocokinetics
353
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
353
Depolarizing Blockers: Mechanism of Action
1.6K
Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
1.6K
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
463
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
463
Peripherally and Centrally Acting Muscle Relaxants: A Comparison
3.4K
Skeletal muscle relaxants can target the central nervous system [CNS] to reduce muscle tension or act directly at the neuromuscular junction to induce temporary paralysis. These two classes of muscle relaxants are called centrally acting muscle relaxants and peripherally acting muscle relaxants. They differ in their action, mechanism, administration route, and clinical uses.
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
3.4K


